These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 19383082)

  • 1. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
    Amarapurkar D; Han KH; Chan HL; Ueno Y;
    J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral hepatitis and hepatocellular carcinoma.
    Marrero CR; Marrero JA
    Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
    Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
    J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
    Robotin MC; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy M; Penman AG
    J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis].
    Bolondi L; Gaiani S; Casali A; Serra C; Piscaglia F
    Radiol Med; 1997; 94(1-2):4-7. PubMed ID: 9424649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can hepatocellular cancer screening increase the proportion of long-term survivors?
    Gannon CJ; Izzo F; Aloia TA; Pignata S; Nasti G; Vallone P; Orlando R; Scordino F; Curley SA
    Hepatogastroenterology; 2009; 56(93):1152-6. PubMed ID: 19760960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
    Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
    Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.
    Lin OS; Keeffe EB; Sanders GD; Owens DK
    Aliment Pharmacol Ther; 2004 Jun; 19(11):1159-72. PubMed ID: 15153169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for hepatocellular carcinoma.
    Merican I
    Med J Malaysia; 1996 Mar; 51(1):12-7. PubMed ID: 10967973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing incidence and pretransplantation screening of hepatocellular carcinoma.
    Everson GT
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S2-10. PubMed ID: 11084078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited hepatocellular carcinoma.
    Villanueva A; Newell P; Hoshida Y
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):725-34. PubMed ID: 20955973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
    Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular cancer: optimal strategies for screening and surveillance.
    Cabibbo G; Craxì A
    Dig Dis; 2009; 27(2):142-7. PubMed ID: 19546552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study.
    McMahon BJ; Bulkow L; Harpster A; Snowball M; Lanier A; Sacco F; Dunaway E; Williams J
    Hepatology; 2000 Oct; 32(4 Pt 1):842-6. PubMed ID: 11003632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
    Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
    Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
    J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances.
    Nouso K; Tanaka H; Uematsu S; Shiraga K; Okamoto R; Onishi H; Nakamura S; Kobayashi Y; Araki Y; Aoki N; Shiratori Y
    J Gastroenterol Hepatol; 2008 Mar; 23(3):437-44. PubMed ID: 17683496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, risk factors and surveillance of hepatocellular carcinoma.
    Cabibbo G; Craxì A
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):352-5. PubMed ID: 20496547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.